These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 4835812)

  • 1. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
    Berry WR; Aronson AE; Darley FL; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 4. Wilson's disease: the role of penicillamine.
    Carmichael BM
    Mil Med; 1969 Oct; 134(11):1336-9. PubMed ID: 4980975
    [No Abstract]   [Full Text] [Related]  

  • 5. Wilson's disease presenting with rickets.
    Cavallino R; Grossman H
    Radiology; 1968 Mar; 90(3):493-4. PubMed ID: 5642287
    [No Abstract]   [Full Text] [Related]  

  • 6. [New views on the etiology, diagnosis and therapy of Wilson's disease].
    Linke A
    Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1273-6. PubMed ID: 4873428
    [No Abstract]   [Full Text] [Related]  

  • 7. Dysarthria in Wilson's disease.
    Berry WR; Darley FL; Aronson AE
    J Speech Hear Res; 1974 Jun; 17(2):169-83. PubMed ID: 4836038
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regression of a Kayser-Fleischer ring in a case of Wilson's disease during penicillamine therapy (author's transl)].
    Hiti H; Harpf H; Wutz W; Schmut O
    Klin Monbl Augenheilkd; 1980 Feb; 176(2):235-8. PubMed ID: 7420971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional disorders of the renal tubules in Wilson's disease].
    Holl H; Troelstra JA
    Ned Tijdschr Geneeskd; 1968 Nov; 112(48):2184-8. PubMed ID: 5704622
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J; Brandt G
    Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
    [No Abstract]   [Full Text] [Related]  

  • 11. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hepatolenticular degeneration. (Wilson's disease).
    Spellberg MA
    Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the course and therapy of a juvenile Wilson's disease case].
    Wallauer P; Harbauer H
    Dtsch Med Wochenschr; 1967 Jun; 92(26):1187-91. PubMed ID: 6027022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Penicillamine treatment of Wilson's disease].
    Falkmer S; Samuelson G; Sjölin S
    Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemolytic episode in a patient with Wilson's disease treated with zinc.
    Shimon I; Moses B; Sela BA; Dolev E
    Isr J Med Sci; 1993 Oct; 29(10):646-7. PubMed ID: 8244665
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychiatric aspects of Wilson's disease (hepatolenticular degeneration): results of psychometric tests during long-term therapy.
    Goldstein NP; Ewert JC; Randall RV; Gross JB
    Am J Psychiatry; 1968 May; 124(11):1555-61. PubMed ID: 4384740
    [No Abstract]   [Full Text] [Related]  

  • 17. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 20. What Wilson's disease and its treatment have taught us about the metabolism of copper. Observations in 27 cases.
    Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
    Med Clin North Am; 1968 Jul; 52(4):989-1001. PubMed ID: 5742073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.